Internal Medicine, Hematology & Oncology · Miami Lakes, FL
NPI
1811018765
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5801 NW 151 St Suite 300
Miami Lakes, FL, 33014
Phone (305) 828-1333
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
323 services
Medicare patients, 2024
42
Average age 75
Drug cost, 2024
$9.3M
3,388 prescriptions
Company payments, 2025
$4,669
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eloy Roman was code 99214 (office e&m - established), 111 times for 40 patients. In total Eloy Roman billed 323 services in 20 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 111 | 40 | $104.42 | $12K |
By year: 2022 $33K for 564 services; 2023 $27K for 440 services; 2024 $20K for 323 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eloy Roman prescribed most often to Medicare patients was Exemestane, with 518 prescriptions and refills. In total Eloy Roman wrote 3,388 Medicare prescriptions that cost $9.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Exemestane Generic | 518 | 726 | 102 | $117K |
| Bicalutamide Generic | 206 | 249 | 67 | $16K |
| Dexamethasone Generic | 205 | 205 | 48 | $2,112 |
| Hydroxyurea Generic | 203 | 236 | 46 | $1,404 |
| Tamoxifen Citrate Generic | 181 | 224 | 30 | $8,639 |
| Anastrozole Generic | 154 | 207 | 38 | $1,507 |
| Prednisone Generic | 141 | 146 | 48 | $565 |
| Folic Acid Generic | 119 | 151 | 29 | $168 |
| Ondansetron Hcl Generic | 107 | 107 | 77 | $1,538 |
| Acyclovir Generic | 95 | 97 | 12 | $1,328 |
| Imatinib Mesylate Generic | 75 | 75 | Under 11 | $43K |
| Abiraterone Acetate Generic | 74 | 74 | 16 | $66K |
| Brukinsa Zanubrutinib | 70 | 70 | Under 11 | $1.0M |
| Lupron Depot Leuprolide Acetate | 65 | 72 | 15 | $152K |
| Ibrance Palbociclib | 61 | 61 | Under 11 | $951K |
Brand drugs: 956 claims; generic drugs: 2,432 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eloy Roman $4,669 ($4,669 in general payments such as food, travel and fees) from 33 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $807.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 28 | $807 |
| Celgene Corporation BMY | 24 | $555 |
| Pfizer Inc. PFE | 18 | $408 |
| Merck Sharp & Dohme LLC MRK | 13 | $321 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $304 |
| Genzyme Corporation SNY | 10 | $298 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 11 | $242 |
| Abbvie Inc. ABBV | 8 | $175 |
| Janssen Biotech, Inc. JNJ | 5 | $172 |
| Array Biopharma Inc PFE | 9 | $159 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.